Dr. Venkata Ranganadha Rao PemmarajuProgram Advisor for Medical IssuesSasakawa Health Foundation As an epidemi […]
VIEWPOINT: Immune-mediated leprosy reactions before, during, and after multidrug therapy (MDT)
カテゴリ: Viewpoints
VIEWPOINT: Leading GPZL to new heights in the global fight against Hansen’s disease
Dr. Ritu GhoshExecutive Director, Global Partnership for Zero Leprosy (GPZL) GPZL welcomed Dr. Ghosh as its ne […]
VIEWPOINT: Commentary on WHO’s Global leprosy (Hansen disease) update, 2023
Dr. Venkata Ranganadha Rao PemmarajuProgram Advisor for Medical IssuesSasakawa Health Foundation As an epidemi […]
VIEWPOINT: Strengthening people’s organizations should be seen as part of the zero leprosy strategy for Africa
Tesfaye Tadesse Haileformer Managing Director, Ethiopian National Association of Persons Affected by Leprosy ( […]
VIEWPOINT: Leprosy as a human rights issue in the 21st century
Dr. Beatriz Miranda GalarzaUnited Nations Special Rapporteur on the elimination of discrimination against pers […]
VIEWPOINT: Despite low numbers, the United States offers unique perspectives in the fight against leprosy
Dr. Jessica K. FairleyAssociate Professor of Medicine, Global Health, and EpidemiologyEmory University Dr. Fai […]
VIEWPOINT: CRADAR-i method promises a breakthrough in point-of-care diagnostic testing for leprosy
Dr. Koichi SuzukiProfessor, Department of Clinical Laboratory ScienceFaculty of Medical Technology, Teikyo Uni […]
VIEWPOINT: A rights-based perspective on stopping transmission
Dr. Alice CruzProgram Advisor for Human Rights Issues, Sasakawa Health FoundationFormer UN Special Rapporteur […]
VIEWPOINT: WHO supports Bangladesh’s new strategic plan
Dr. Bardan Jung RanaWHO RepresentativeWorld Health Organization Country Office for Bangladesh Dr. Bardan is a […]
VIEWPOINT: “Interruption of transmission”: A challenge
Dr. Paul FineProfessor of Communicable Disease EpidemiologyLondon School of Hygiene & Tropical Medicine Dr […]